RA Capital Management Portfolio Companies

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

PepGen is empowering nucleic acid therapeutics to go the distance.

KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Empatica is an affective computing company focused on human data analytics.

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Ocelot Bio brings new treatment options to patients with severe liver disease.

AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology.

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.